Effects of Buteyko Breathing and Chest Wall Mobilization on Lung Function in Smokers
Combined Effects of Buteyko Breathing Technique and Chest Wall Mobilization on Pulmonary Functions and Quality of Life in Chronic Smokers
This study is testing if a breathing technique combined with chest exercises can improve lung function and quality of life for people who smoke.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 40 Years to 55 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Trial ID | NCT06537479 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the impact of the Buteyko breathing technique combined with chest wall mobilization on pulmonary functions and quality of life in chronic smokers. Participants will be randomly assigned to one of two groups: one receiving both interventions and the other receiving only the breathing technique. The study will measure lung function using spirometry and assess quality of life through the St George Quality of Life Questionnaire. The trial aims to complete within 10 months following ethical approval.
Who should consider this trial
Good fit: Ideal candidates are current or long-term smokers aged 40-55 with reduced lung function.
Not a fit: Patients with neurological or musculoskeletal disorders, or those with existing pulmonary complications will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve lung function and enhance the quality of life for chronic smokers.
How similar studies have performed: While the Buteyko breathing technique has been studied, the combination with chest wall mobilization is a novel approach that has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Both male and female participants were included * The age of participants was 40 -55 years. * Individuals who fulfilled the criteria of smoking which is calculated by multiplying the number of packs smoked per day by the number of years smoked were included. * Individuals who are current smokers or history of long-term smoking were included. * Predicted values FEV1 \< 75% and FEV1/FVC \<70% Exclusion Criteria: * Participants with neurological disorders were excluded * Participants with musculoskeletal disorders were excluded as it affects the physical activity of the 6-minute walk test. * Participants having any pulmonary complications or lung disease were excluded. * Participants previously involved in any other exercise or physical activity were excluded.
Where this trial is running
Lahore, Punjab Province
- University of Lahore Teaching Hospital — Lahore, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Tasneem Shehzadi, Mphil — Riphah International University
- Study coordinator: Kinza Saleem, DPT
- Email: Kinza.saleem81@gmail.com
- Phone: 03067639002
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.